NovaBay Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $2,309 | $2,309 | $2,441 |
Gross Profit | -38 | -55 | 1,502 | 1,593 |
EBITDA | -1,926 | -3,275 | -979 | |
EBIT | -1,964 | -3,330 | -1,074 | |
Net Income | -1,922 | 7,670 | -1,212 | -1,212 |
Net Change In Cash | 0 | 2,309 | 2,309 | 2,441 |
Free Cash Flow | -2,991 | -1,324 | -972 | -1,948 |
Cash | 5,344 | 8,467 | 430 | 776 |
Basic Shares | 5,818 | 5,415 | 4,885 | 3,710 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $9,781 | $10,455 | $14,404 | $8,421 |
Gross Profit | 6,481 | 6,084 | 7,781 | 5,645 |
EBITDA | -5,925 | -4,800 | -7,197 | -8,743 |
EBIT | -6,306 | -5,003 | -7,680 | -8,862 |
Net Income | -7,223 | -9,640 | -16,265 | -6,559 |
Net Change In Cash | 9,781 | 10,455 | 14,404 | 8,421 |
Free Cash Flow | -5,189 | -4,150 | -6,766 | -9,244 |
Cash | 430 | 3,130 | 5,362 | 7,504 |
Basic Shares | 3,396 | 120 | 46 | 35 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$0.34 |
2025-03-31 | -$0.40 |
2024-12-31 | -$0.39 |
2024-09-30 | -$0.59 |
